Anesthetic techniques and cancer recurrence after surgery

Vincenzo Fodale, Maria G D'Arrigo, Stefania Triolo, Stefania Mondello, Domenico La Torre, Vincenzo Fodale, Maria G D'Arrigo, Stefania Triolo, Stefania Mondello, Domenico La Torre

Abstract

Many of the most common anesthetics are used in surgical oncology, yet effects on cancer cells are still not known. Anesthesia technique could differentially affect cancer recurrence in oncologic patients undergoing surgery, due to immunosuppression, stimulation of angiogenesis, and dissemination of residual cancer cells. Data support the use of intravenous anesthetics, such as propofol anesthesia, thanks to antitumoral protective effects inhibiting cyclooxygenase 2 and prostaglandins E2 in cancer cells, and stimulation of immunity response; a restriction in the use of volatile anesthetics; restriction in the use of opioids as they suppress humoral and cellular immunity, and their chronic use favors angiogenesis and development of metastases; use of locoregional anesthesia compared with general anesthesia, as locoregional appears to reduce cancer recurrence after surgery. However, these findings must be interpreted cautiously as there is no evidence that simple changes in the practice of anesthesia can have a positive impact on postsurgical survival of cancer patients.

References

    1. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. The role of the perioperative period in recurrence after cancer surgery. Anesthesia and Analgesia. 2010;110(6):1636–1643.
    1. Kvolik S, Glavas-Obrovac L, Bares V, Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sciences. 2005;77(19):2369–2383.
    1. Mammoto T, Mukai M, Mammoto A, et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Letters. 2002;184(2):165–170.
    1. Itoh T, Namba T, Fukuda K, Semenza GL, Hirota K. Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Letters. 2001;509(2):225–229.
    1. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and Analgesia. 2003;97(5):1331–1339.
    1. Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Disease. 2006;26(1):99–114.
    1. Yamashita J-I, Kurusu Y, Fujino N, Saisyoji T, Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. Journal of Thoracic and Cardiovascular Surgery. 2000;119(5):899–905.
    1. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain, Behavior, and Immunity. 2003;17(1):S27–S36.
    1. Demicheli R, Miceli R, Moliterni A, et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Annals of Oncology. 2005;16(9):1449–1457.
    1. Rosendahl W, Schulz U, Teufel T, Irtel von Brenndorf C, Gupta D. Surgical stress and neuroendocrine responses in infants and children. Journal of Pediatric Endocrinology and Metabolism. 1995;8(3):187–194.
    1. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology. 2001;94(6):1066–1073.
    1. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148.
    1. Melamed R, Rosenne E, Shakhar K, Schwartz Y, Abudarham N, Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a β-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain, Behavior, and Immunity. 2005;19(2):114–126.
    1. Page GG. Surgery-induced immunosuppression and postoperative pain management. AACN Clinical Issues. 2005;16(3):302–418.
    1. Tartter PI, Steinberg B, Barron DM, Martinelli G. The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Archives of Surgery. 1987;122(11):1264–1268.
    1. Koda K, Saito N, Takiguchi N, Oda K, Nunomura M, Nakajima N. Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas. International Surgery. 1997;82(2):190–193.
    1. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. American Journal of Gastroenterology. 2001;96(2):574–578.
    1. Fujisawa T, Yamaguchi Y. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer. 1997;79(3):474–481.
    1. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer. 1996;77:1226–11243.
    1. Schantz SP, Savage HE, Racz T, et al. Immunologic deteminants of head and neck cancer response to induction chemotherapy. Journal of Clinical Oncology. 1989;7(7):857–864.
    1. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. Journal of Anesthesia. 2008;22(3):263–277.
    1. Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. The Lancet Oncology. 2004;5(10):617–625.
    1. Thaker PH, Sood AK. Neuroendocrine influences on cancer biology. Seminars in Cancer Biology. 2008;18(3):164–170.
    1. Sood AK, Bhatty R, Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clinical Cancer Research. 2006;12(2):369–375.
    1. Landen CN, Jr., Lin YG, Pena GNA, et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Research. 2007;67(21):10389–10396.
    1. Lutgendorf SK, Cole S, Costanzo E, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clinical Cancer Research. 2003;9(12):4514–4521.
    1. Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Annals of Surgical Oncology. 2008;15(7):2042–2052.
    1. Yang EV, Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Research. 2006;66(21):10357–10364.
    1. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers. Cancer Research. 2001;61(7):2866–2869.
    1. Kundu JK, Surh Y-J. Inflammation: gearing the journey to cancer. Mutation Research. 2008;659(1-2):15–30.
    1. Sacerdote P, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain, Behavior, and Immunity. 1994;8(3):251–260.
    1. Shavit Y, Martin FC, Yirmiya R, et al. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behavior and Immunity. 1987;1(4):318–328.
    1. Lewis JW, Shavit Y, Terman GW. Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides. 1983;4(5):635–638.
    1. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90(1-2):191–199.
    1. Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. European Journal of Cancer Prevention. 2008;17(3):269–272.
    1. Arain MR, Buggy DJ. Anesthesia for cancer patients. Current Opinion in Anaesthesiology. 2007;20:247–253.
    1. Santamaria LB, Schifilliti D, La Torre D, Fodale V. Drugs of anaesthesia and cancer. Surgical Oncology. 2010;19(2):63–81.
    1. Kawaraguchi Y, Horikawa YT, Murphy AN, et al. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology. 2011;115(3):499–508.
    1. Jun R, Gui-He Z, Xing-Xing S, Hui Z, Li-Xian X. Isoflurane enhances malignancy of head and neck squamous cell carcinoma cell lines: a preliminary study in vitro. Oral Oncology. 2011;47(5):329–333.
    1. Schifilliti D, Mondello S, D’Arrigo MG, Chill G, Fodale V. Genotoxic effects of anesthetic agents: an update. Expert Opinion on Drug Safety. 2011;10(6):891–899.
    1. Inada T, Kubo K, Kambara T, Shingu K. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Canadian Journal of Anesthesia. 2009;56(3):222–229.
    1. Shakhar G, Ben-Eliyahu S. In vivo β-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. Journal of Immunology. 1998;160(7):3251–3258.
    1. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesthesia and Analgesia. 1998;86(6):1289–1293.
    1. Zheng W, Li Y-P, Lai R-C, Lu Y-L, Shen Z-W, Wang X-D. Effects of neuraxial block and general anesthesia on tumor metastasis in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(12):2218–2220.
    1. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–664.
    1. Deegan CA, Buggy DJ, Moriarty DC, Sessler DI, Kavanagh DP. Anesthetic technique and the cytokine response to primary breast cancer surgery. Proceedings of the ASA Annual Meeting; 2008; Orlando, Fla, USA.
    1. Yoon JR, Whipple RA, Balzer EM, et al. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Research and Treatment. 2011;129(3):691–701.
    1. Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang Y-L. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesthesia and Intensive Care. 2008;36(1):74–78.
    1. Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia. 2010;65(5):478–482.
    1. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109(2):180–187.
    1. Tsui BCH, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Canadian Journal of Anesthesia. 2010;57(2):107–112.
    1. Xing C-Y, Wu M-Y, Fan H-P. Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(2):284–287.
    1. Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. British Journal of Anaesthesia. 2010;105(2):145–149.
    1. Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. British Journal of Anaesthesia. 2011;106(6):814–822.
    1. Gupta A, Björnsson A, Fredriksson M, Hallböök O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden. British Journal of Anaesthesia. 2011;107(2):164–170.
    1. De Oliveira GS, Jr., Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Regional Anesthesia and Pain Medicine. 2011;36(3):271–277.
    1. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesthesia and Analgesia. 2008;107(1):325–332.
    1. Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Research. 2000;10(2):165–169.
    1. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. International Journal of Cancer. 1999;80(6):880–888.
    1. Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research. 2002;62(15):4491–4498.
    1. Singhal PC, Kapasi AA, Reddy K, Franki N, Gibbons N, Ding G. Morphine promotes apoptosis in jurkat cells. Journal of Leukocyte Biology. 1999;66(4):650–658.
    1. Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain. 1993;54(1):21–28.
    1. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats: dose and timing study. NeuroImmunoModulation. 2004;11(4):255–260.
    1. Yeager MP, Procopio MA, Deleo JA, Arruda JL, Hildebrandt L, Howell AL. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16+ lymphocytes in humans. Anesthesia and Analgesia. 2002;94(1):94–99.
    1. Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesthesia and Analgesia. 2011;112(3):558–567.
    1. Min TJ, Park S-H, Ji Y-H, et al. Morphine attenuates endothelial cell adhesion molecules induced by the supernatant of LPS-stimulated colon cancer cells. Journal of Korean Medical Science. 2011;26(6):747–752.
    1. Page GG, Mcdonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. British Journal of Anaesthesia. 1998;81(2):216–223.
    1. Fuggetta MP, Di Francesco P, Falchetti R, et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. Journal of Experimental and Clinical Cancer Research. 2005;24(2):255–263.
    1. Yeager MP, Colacchio TA, Yu CT, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 1995;83(3):500–508.
    1. Beilin B, Shavit Y, Hart J, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesthesia and Analgesia. 1996;82(3):492–497.
    1. Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat M-O, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer?. Methodology of a multicenter randomized trial. Contemporary Clinical Trials. 2008;29(4):517–526.
    1. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. British Journal of Anaesthesia. 2009;103(5):685–690.
    1. Forget P, Collet V, Lavand’homme P, De Kock M. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. European Journal of Anaesthesiology. 2010;27(3):233–240.
    1. Curatolo M. Adding regional analgesia to general anaesthesia: increase of risk or improved outcome? European Journal of Anaesthesiology. 2010;27(7):586–591.
    1. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. British Journal of Anaesthesia. 2010;105(2):106–115.
    1. Wuethrich PY, Schmitz S-FH, Kessler TM, et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology. 2010;113(3):570–576.
    1. Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer. Anesthesiology. 2010;113(5):1118–1125.
    1. Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Regional Anesthesia and Pain Medicine. 2010;35(6):490–495.
    1. Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113(1):27–34.
    1. Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. British Medical Journal. 2011;342, article d1491
    1. Forget P, Tombal B, Scholtès J-L, et al. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? European Journal of Anaesthesiology. 2011;28(12):830–835.
    1. Tavare AN, Perry NJS, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. International Journal of Cancer. 2012;130(6):1237–1250.
    1. Lindholm M-L, Granath F, Eriksson LI, Sandin R. Malignant disease within 5 years after surgery in relation to duration of sevoflurane anesthesia and time with bispectral index under 45. Anesthesia and Analgesia. 2011;113(4):778–783.
    1. Palm D, Lang K, Niggemann B, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers. International Journal of Cancer. 2006;118(11):2744–2749.
    1. Afsharimani B, Cabot P, Parat M-O. Morphine and tumor growth and metastasis. Cancer and Metastasis Reviews. 2011;30(2):225–238.
    1. Bovill JG. Surgery for cancer: does anesthesia matter? Anesthesia and Analgesia. 2010;110(6):1524–1526.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa